Immediate Impact
13 by Nobel laureates 26 from Science/Nature 82 standout
Citing Papers
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
2022 Standout
Psoriasis
2021 Standout
Works of Michael Heffernan being referenced
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
2015 Standout
Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Heffernan | 562 | 1122 | 495 | 1601 | 64 | 3.1k | |
| Thomas Barnetche | 210 | 597 | 402 | 1715 | 123 | 4.4k | |
| Amit K. Dey | 654 | 238 | 173 | 1100 | 97 | 2.7k | |
| Wietske Kievit | 91 | 461 | 576 | 1115 | 169 | 4.0k | |
| Bénédicte Lebrun‐Vignes | 595 | 293 | 512 | 467 | 118 | 3.6k | |
| Pierre Clerson | 1197 | 434 | 1454 | 412 | 104 | 4.1k | |
| Anja Strangfeld | 184 | 212 | 381 | 939 | 134 | 3.7k | |
| P. A. Bacon | 137 | 316 | 411 | 953 | 63 | 3.6k | |
| Marian T. McEvoy | 55 | 1169 | 473 | 1249 | 75 | 3.1k | |
| James B. Whitmore | 403 | 104 | 172 | 1503 | 63 | 3.9k | |
| S. E. Gabriel | 276 | 179 | 375 | 435 | 38 | 2.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...